Upon analysis of the FOXP family in the OncoPrint module on cBioPortal, the results revealed that gene alterations in FOXP1/2/3/4 occurred in 3%, 3%, 2.2%, and 2.7% of the NSCLC samples, respectively (Figure 13A). Here, FOXP1 is linked to non-small cell lung carcinoma.